Redx is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic disease.
Non-Executive Director: |
Natalie Berner, Joseph Anderson |
Non-Executive Chairman: |
Jane Griffiths |
Chief Executive Officer : |
Lisa Anson |
Independent Non-Executive Director: |
Bernhard Kirschbaum, Peter Presland, Rob Scott |
Address: |
Block 33, Mereside, Alderley Park, United Kingdom |
Phone: |
+44 (0)1625 469900 |
Fax: |
|
Website: |
http://redxpharma.com |
Email: |
|